AIP
PNT

Ameritas Investment Partners’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Ameritas Investment Partners’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,990
Closed -$60K – 3115
2023
Q3 		$60K Buy
8,990
+2,150
+31% +$17.9K ﹤0.01% 1984
2023
Q2 		$62K Hold
6,840
– – ﹤0.01% 1910
2023
Q1 		$49.7K Hold
6,840
– – ﹤0.01% 1989
2022
Q4 		$48.4K Buy
6,840
+1,286
+23% +$9.54K ﹤0.01% 2076
2022
Q3 		$42K Hold
5,554
– – ﹤0.01% 2122
2022
Q2 		$37K Buy
+5,554
New +$42.5K ﹤0.01% 2200

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Ameritas Investment Partners's PNT Position: Q4 2023 in Review

Ameritas Investment Partners sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 8,990 shares — an estimated $60K sold.

Ameritas Investment Partners first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $62K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Ameritas Investment Partners reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Ameritas Investment Partners sold 8,990 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $60K.
  • Ameritas Investment Partners first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • Ameritas Investment Partners's POINT Biopharma Global Inc. Common Stock position peaked at $62K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Ameritas Investment Partners's 13F filing for Q4 2023, filed 14 Feb 2024.